A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer

Carmelo Nucera _

PDF  |  How to cite

Oncotarget. 2019; 10:686-687. https://doi.org/10.18632/oncotarget.26591

Metrics: PDF 1477 views  |   ?  

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26591